Biolight Life Sciences Stock

Biolight Life Sciences ROA 2025

Biolight Life Sciences ROA

-0.21

Ticker

BOLT.TA

ISIN

IL0010952237

In 2025, Biolight Life Sciences's return on assets (ROA) was -0.21, a -73.09% increase from the -0.78 ROA in the previous year.

Biolight Life Sciences Aktienanalyse

What does Biolight Life Sciences do?

Biolight Life Sciences Ltd is a global company specializing in the development, production, and marketing of medical devices and products. It was founded in China in 1993 and has since relocated its headquarters to Israel. Biolight has evolved from a small company to a leading provider of medical devices and products that help improve patient treatment and optimize healthcare. The company's business model is based on selling medical devices and products used in diagnosis, monitoring, and treatment of patients. It continually strives to improve its products through research and development to enhance healthcare worldwide. Biolight believes that cooperative technologies and services can create synergistic value that benefits patients. Its various divisions include monitoring and diagnostic devices, cardiology products, and emergency medicine products. Biolight offers a wide range of products to ensure quality healthcare. Its monitoring and diagnostic devices measure various physiological parameters such as blood pressure, heart rate, respiration, oxygen saturation, and temperature. The cardiology products are tailored to the needs of heart patients and include EKG devices, long-term EKG systems, and Holter devices. The emergency medicine products treat life-threatening conditions such as heart attacks, strokes, and respiratory distress, thereby saving lives. To ensure a high-quality healthcare system, it is essential for medical devices and products to meet the highest standards. Biolight is aware of this and is committed to offering products that comply with the strictest international quality standards such as ISO 13485, CE, and FDA. Biolight has a broad global presence with branches and subsidiaries in numerous countries such as the USA, China, India, Germany, Spain, and France. This global presence enables the company to understand and meet the needs of patients and medical personnel in different parts of the world. Biolight also collaborates with partners and customers to further improve its products and services and meet market demands. Overall, Biolight has made a sustainable contribution to improving healthcare. Through its continuous research and development, products and services, and global presence, the company has established itself as a key player in the medical technology industry. By working with partners and customers, Biolight can contribute to ensuring that patients worldwide have access to the best healthcare. Biolight Life Sciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Biolight Life Sciences's Return on Assets (ROA)

Biolight Life Sciences's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Biolight Life Sciences's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Biolight Life Sciences's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Biolight Life Sciences’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Biolight Life Sciences stock

What is the Return on Assets (ROA) of Biolight Life Sciences this year?

The Return on Assets (ROA) of Biolight Life Sciences is -0.21 undefined this year.

What was the ROA of Biolight Life Sciences compared to the previous year?

The ROA of Biolight Life Sciences has increased by -73.09% compared to the previous year.

What consequences do high ROA have for investors of Biolight Life Sciences?

A high ROA is advantageous for investors of Biolight Life Sciences, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Biolight Life Sciences?

A low ROA can be unfavorable for investors of Biolight Life Sciences as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Biolight Life Sciences affect the company?

An increase in ROA of Biolight Life Sciences can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Biolight Life Sciences impact the company?

A reduction in the ROA of Biolight Life Sciences can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Biolight Life Sciences?

Some factors that can influence the ROA of Biolight Life Sciences include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Biolight Life Sciences important for investors?

The ROA of Biolight Life Sciences is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Biolight Life Sciences take to improve ROA?

To improve ROA, Biolight Life Sciences can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Biolight Life Sciences pay?

Over the past 12 months, Biolight Life Sciences paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Biolight Life Sciences is expected to pay a dividend of 0 ILS.

What is the dividend yield of Biolight Life Sciences?

The current dividend yield of Biolight Life Sciences is .

When does Biolight Life Sciences pay dividends?

Biolight Life Sciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Biolight Life Sciences?

Biolight Life Sciences paid dividends every year for the past 0 years.

What is the dividend of Biolight Life Sciences?

For the upcoming 12 months, dividends amounting to 0 ILS are expected. This corresponds to a dividend yield of 0 %.

In which sector is Biolight Life Sciences located?

Biolight Life Sciences is assigned to the 'Health' sector.

Wann musste ich die Aktien von Biolight Life Sciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Biolight Life Sciences from 6/5/2025 amounting to 0 ILS, you needed to have the stock in your portfolio before the ex-date on 6/5/2025.

When did Biolight Life Sciences pay the last dividend?

The last dividend was paid out on 6/5/2025.

What was the dividend of Biolight Life Sciences in the year 2024?

In the year 2024, Biolight Life Sciences distributed 0 ILS as dividends.

In which currency does Biolight Life Sciences pay out the dividend?

The dividends of Biolight Life Sciences are distributed in ILS.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Biolight Life Sciences

Our stock analysis for Biolight Life Sciences Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Biolight Life Sciences Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.